VAN ECK ASSOCIATES CORP - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 232 filers reported holding CANTEL MEDICAL CORP in Q3 2017. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$1,597,000
+14.1%
20,002
+12.6%
0.00%0.0%
Q4 2020$1,400,000
-38.2%
17,758
-65.6%
0.00%0.0%
Q3 2020$2,266,000
-6.5%
51,564
-5.9%
0.00%0.0%
Q2 2020$2,424,000
+71.4%
54,796
+39.1%
0.00%
-42.9%
Q1 2020$1,414,000
+22.4%
39,401
+141.9%
0.01%
+75.0%
Q4 2019$1,155,000
+0.3%
16,290
+5.7%
0.00%
-20.0%
Q3 2019$1,152,000
-13.1%
15,405
-6.2%
0.01%
-16.7%
Q2 2019$1,325,000
+22.1%
16,428
+1.3%
0.01%
+20.0%
Q1 2019$1,085,000
+34.0%
16,215
+49.0%
0.01%
+25.0%
Q4 2018$810,000
-1.6%
10,879
+21.7%
0.00%0.0%
Q3 2018$823,000
-2.5%
8,941
+4.2%
0.00%0.0%
Q2 2018$844,000
+2.6%
8,578
+16.2%
0.00%0.0%
Q1 2018$823,000
+30.6%
7,383
+20.6%
0.00%
+33.3%
Q4 2017$630,000
-4.5%
6,122
-12.7%
0.00%0.0%
Q3 2017$660,000
-14.2%
7,010
-28.9%
0.00%
-25.0%
Q2 2017$769,000
-1.7%
9,865
+1.0%
0.00%
+33.3%
Q1 2017$782,000
+7.3%
9,769
+5.5%
0.00%
-25.0%
Q4 2016$729,000
+13.6%
9,261
+12.5%
0.00%
+33.3%
Q3 2016$642,000
-6.3%
8,233
-17.4%
0.00%
-25.0%
Q2 2016$685,000
+9.6%
9,966
+13.7%
0.00%0.0%
Q1 2016$625,000
+13.2%
8,762
-1.4%
0.00%0.0%
Q4 2015$552,000
-3.3%
8,887
-11.7%
0.00%0.0%
Q3 2015$571,000
-1.6%
10,065
-6.8%
0.00%
+33.3%
Q2 2015$580,000
+1.8%
10,805
-10.0%
0.00%0.0%
Q1 2015$570,000
+13.5%
12,009
+3.5%
0.00%0.0%
Q4 2014$502,000
+12.1%
11,602
-11.0%
0.00%
+50.0%
Q3 2014$448,000
-15.3%
13,034
-9.7%
0.00%0.0%
Q2 2014$529,000
+12.3%
14,440
+3.4%
0.00%0.0%
Q1 2014$471,000
-1.7%
13,963
-1.2%
0.00%0.0%
Q4 2013$479,000
-15.8%
14,134
-20.9%
0.00%
-33.3%
Q3 2013$569,000
+14.3%
17,858
+21.3%
0.00%0.0%
Q2 2013$498,00014,7180.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q3 2017
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of CANTEL MEDICAL CORP shareholders